Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

220.91
+5.402.51%
Post-market: 220.910.00000.00%18:10 EST
Volume:1.13M
Turnover:249.76M
Market Cap:10.87B
PE:-144.39
High:222.37
Open:217.82
Low:216.88
Close:215.51
52wk High:222.37
52wk Low:91.86
Shares:49.22M
Float Shares:48.62M
Volume Ratio:1.54
T/O Rate:2.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5300
EPS(LYR):0.2004
ROE:-2.19%
ROA:4.33%
PB:3.19
PE(LYR):1,102.30

Loading ...

Charles River Exec Says Co Is Looking to Expand Its Services Portfolio in China - Jefferies Healthcare Conf

THOMSON REUTERS
·
Nov 18, 2025

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Nov 18, 2025

Argus Upgrades Charles River Laboratories International to Buy From Hold, Price Target is $200

MT Newswires Live
·
Nov 17, 2025

Charles River: SEC concluded inquiry into company, not recommeding enforcement

TIPRANKS
·
Nov 17, 2025

SEC Ends Probe Into Charles River Laboratories With No Enforcement Action

Reuters
·
Nov 17, 2025

Charles River Laboratories-Investigation Was About Inquiry Requesting to Give Information Related to Sourcing Non-Human Primates & Related Disclosures

THOMSON REUTERS
·
Nov 17, 2025

Charles River Laboratories International Inc - SEC Concludes Investigation, No Action Against Charles River Labs - SEC Filing

THOMSON REUTERS
·
Nov 17, 2025

Charles River Laboratories Presents at Jefferies Global Healthcare Conference

Reuters
·
Nov 17, 2025

Charles River Laboratories International Inc : Argus Research Raises to Buy From Hold

THOMSON REUTERS
·
Nov 17, 2025

Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Nov 14, 2025

Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD

GlobeNewswire
·
Nov 13, 2025

Applied Therapeutics Reports Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 13, 2025

Did Lower Guidance and Weak Earnings Just Shift Charles River Laboratories' (CRL) Investment Narrative?

Simply Wall St.
·
Nov 13, 2025

Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

GlobeNewswire
·
Nov 12, 2025

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Nov 12, 2025

Charles River Labs Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Nov 12, 2025

Morgan Stanley Adjusts Charles River Laboratories International PT to $185 From $170, Maintains Equal Weight Rating

MT Newswires Live
·
Nov 11, 2025

TD Cowen Adjusts Price Target on Charles River Laboratories International to $197 From $205

MT Newswires Live
·
Nov 10, 2025

U.S. RESEARCH ROUNDUP-DoorDash, Honeywell, Zscaler

Reuters
·
Nov 10, 2025

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Nov 07, 2025